Abiopharma

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001415889-25-022088 Size: 6 KB

New Form 144 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-08-15 AccNo: 0001950047-25-005932 Size: 4 KB

New Form S-8 - NeuroSense Therapeutics Ltd. Filed: 2025-08-15 AccNo: 0001213900-25-077513 Size: 313 KB

New Form SC TO-T/A - iTeos Therapeutics, Inc. Filed: 2025-08-15 AccNo: 0001140361-25-031525 Size: 629 KB

New Form 424B3 - SOPHiA GENETICS SA Filed: 2025-08-15 AccNo: 0000950103-25-010373 Size: 433 KB

New Form 8-K - NEUROONE MEDICAL TECHNOLOGIES Corp Filed: 2025-08-15 AccNo: 0001213900-25-077511 Size: 213 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001628280-25-040540 Size: 52 KB

Cardinal Health Board of Directors Approves Quarterly Dividend

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001628280-25-040535 Size: 17 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001415889-25-022085 Size: 8 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001722482-25-000202 Size: 4 KB

New Form 3 - Keros Therapeutics, Inc. Filed: 2025-08-15 AccNo: 0001415889-25-022079 Size: 14 KB

New Form 3 - ECOLAB INC. Filed: 2025-08-15 AccNo: 0001415889-25-022078 Size: 21 KB

Blanchfield Paul sold 3.1k shares of Lantheus Holdings, Inc. (LNTH) at average price $53.57 Filed: 2025-08-15 AccNo: 0001062993-25-014521 Size: 4 KB

adjusted position in 0 shares of () Filed: 2025-08-15 AccNo: 0001723128-25-000052 Size: 5 KB